(Australia-NewsWire.Com, January 06, 2018 ) The key drivers for the vibration sensor market are the installation of sensors in automobiles for reducing accidents and growing applications of sensors across diversified industries. Vibration sensor or Vibration transducer is used for testing impact...
(Australia-NewsWire.Com, January 06, 2018 ) Asia-Pacific Autoimmune Monoclonal Antibodies market is expected to reach USD 2,181.4 million by 2021 from USD 1,559.7 million in 2016, growing at a CAGR of 6.94% during forecast period 2016-2021. Irregular functioning of humans’ immune system results...
(Australia-NewsWire.Com, January 06, 2018 ) The key drivers for the vibration sensor market are the installation of sensors in automobiles for reducing accidents and growing applications of sensors across diversified industries. Vibration sensor or Vibration transducer is used for testing impact...
(Australia-NewsWire.Com, January 06, 2018 ) The Asia-Pacific Biochips Market was worth $1.73 billion in 2016 and estimated to be growing at a CAGR of 22.94%, to reach $4.86 billion by 2021. The medicinal importance of miniaturised biological microarray chips, generally known as biochips, has produced...
(Australia-NewsWire.Com, January 05, 2018 ) The Asia Pacific Veterinary Healthcare Market is valued at $5.13 billion market as of 2016 and is estimated to be a $9.29 billion market by 2021 with a tremendous CAGR of 12.6% in the review period. Veterinary medicines helps in diagnosing, treating and...
(Australia-NewsWire.Com, January 05, 2018 ) The Asia-pacific Bovine Respiratory Disease Treatment Market has been estimated at USD 3.92 million in 2016 and is projected to reach USD 14.58 million by 2021, at a CAGR of 30.05% during the forecast period from 2016 to 2021. In the Asia Pacific region,...
(Australia-NewsWire.Com, January 05, 2018 ) Asia Pacific Hormone Therapy (HT) remains the most effective option to treat menopausal symptoms. There are many good clinical data to indicate that the use of HT started in early menopause is effective and safe. The Asia-Pacific Hormone Replacement Therapy...
(Australia-NewsWire.Com, January 05, 2018 ) The Asia-Pacific Preventive Vaccine market is valued at $4.84 Billion in 2015 and is estimated to reach $9.27 billion by the end of 2020 with a CAGR of 13.89 %. Recent increase in the demand is owed to the rising incidences of cancer & HIV cases. World...
(Australia-NewsWire.Com, January 05, 2018 ) The Asia-Pacific open MRI Systems Market was worth USD 470 million in 2016 and is expected to reach USD 740 million by 2021 with a CAGR of 9.40%. MRI is a scan which utilizes magnetic field and pulses from Radio wave energy to make pictures of internal...
(Australia-NewsWire.Com, January 05, 2018 ) Asia Pacific Drug Delivery Devices market USD 188.67 billion in 2016 and expected to be USD 302.75 billion by 2021, growing at a CAGR of 9.92%. The Asian injectable Drug Delivery Devices market has high prevalence of sicknesses, for example, diabetes in...
(Australia-NewsWire.Com, January 05, 2018 ) The Asia-Pacific Anaesthesia and Respiratory Devices Market was worth USD 3.48 billion in 2016 and estimated to be growing at a CAGR of 9.61%, to reach USD 5.56 billion by 2021. Asia Pacific is expected to have the highest growth rate during the forecast...
(Australia-NewsWire.Com, January 05, 2018 ) The North America Market is Chromatography Instrumentation expected to reach USD 3.25 billion by 2021 from USD 2.48 billion in 2016, growing at a CAGR of 5.6%. The Chromatography Instrumentation market is forecasted to show great potential over the mentioned...
(Australia-NewsWire.Com, January 05, 2018 ) The report “Acidity Regulators Market by Product Type (Lactic Acid, Citric Acid, Acetic Acid, Malic Acid, Phosphoric Acid), by Application (Sauces, Dressings & Condiments, Beverages, Processed Food, Bakers & Confectionery), and by Region - Global Industry...
(Australia-NewsWire.Com, January 05, 2018 ) Asia Pacific Spine Biologics Market was worth USD 414 million in 2016 and estimated to be growing at a CAGR of 4.9%, to reach USD 525.86 million by 2021. Spine biologics are used during spine fusion surgery for the treatment of spinal deformities such...
(Australia-NewsWire.Com, January 03, 2018 ) The Asia-Pacific Diabetic Retinopathy Market has been estimated at USD 1.46 billion in 2016 and is projected to reach USD 2.15 billion by 2021, at a CAGR of 7.94% during the forecast period from 2016 to 2021. Asia is predicted to show the wealthy growth...